IDO1 and neoplasm: Indoleamine 2,3-dioxygenase 1 (IDO1) is an intracellular immune checkpoint highly expressed by both tumor and immune cells in the TME, where it mediates the ‘off’ signal that blocks T cells from killing cancer cells.